Eating disorders in adolescents represent complex psychiatric conditions often intertwined with additional mental health challenges, such as anxiety, depression, or obsessive-compulsive disorder. This comorbidity presents formidable barriers to effective treatment, necessitating personalized and multifaceted therapeutic regimens. The corrected study design emphasizes the strategic integration of family dynamics into the therapeutic milieu, positing that by situating treatment within the familial home, clinicians can leverage naturalistic contexts to enhance engagement, monitor progress more accurately, and foster sustainable behavioral change.

The scientific rationale articulated in the correction articulates a departure from conventional clinical paradigms. Instead of relying solely on hospital or clinic-based interventions, this home-centered FBT model capitalizes on the family’s proximal influence on the adolescent’s daily experiences. By embedding treatment protocols into everyday routines, this approach facilitates real-time responsiveness and adaptability, which are crucial in addressing the fluctuating symptoms that typify eating disorders. Moreover, it aligns with contemporary mental health frameworks emphasizing patient-centered care and ecological validity.

From a methodological perspective, the mixed methods design of the trial merges quantitative metrics with qualitative insights, offering a nuanced and robust assessment framework. Quantitative data is anticipated to capture measures such as symptom severity, treatment adherence, and psychological well-being, employing standardized clinical scales. Concurrently, qualitative components encompassing in-depth interviews and observational data will elucidate subjective experiences, familial interactions, and contextual factors influencing therapeutic outcomes. This dual approach promises a comprehensive understanding of efficacy and implementation challenges.

The correction elucidates specific modifications to the original study design, enhancing methodological rigor and relevance. Key amendments pertain to participant selection criteria, data collection techniques, and analytic strategies. These refinements seek to optimize the balance between scientific precision and ecological authenticity, thereby augmenting the translational potential of findings into clinical practice. Such precision is indispensable when dissecting the intricate interplay between eating disorders and coexisting psychiatric symptoms within heterogeneous adolescent populations.

A pivotal aspect of this home-based FBT model lies in its emphasis on family empowerment and education. By equipping parents and caregivers with therapeutic tools and cognitive frameworks, the treatment fosters an environment conducive to recovery. This empowerment paradigm leverages the familial unit not merely as passive recipients but active agents in the intervention process. The approach resonates with developmental psychology theories, emphasizing attachment, communication patterns, and parental responsiveness as mediators of mental health trajectories.

The correction also foregrounds the importance of considering comorbid mental health conditions as integral components rather than ancillary challenges. Adolescents with overlapping diagnoses require synchronized therapeutic strategies that address the multifactorial etiologies and symptom constellations. The trial’s design incorporates mechanisms to tailor interventions to individual clinical profiles, ensuring that treatment modalities are neither monolithic nor excessively compartmentalized. This reflects an advanced understanding of psychiatric comorbidity complexities.

Furthermore, this study’s contextualization within the Dutch and international research ecology is noteworthy. By involving institutions such as Karakter Child and Adolescent Psychiatry in Nijmegen, the University of Groningen, and UCSF Weill Institute for Neurosciences, the research exemplifies a cross-cultural and interdisciplinary collaboration. This fusion enhances the external validity of the trial and offers a blueprint for global adaptation, potentially revolutionizing treatment models in diverse healthcare settings.

Technologically, the mixed methods trial capitalizes on emerging digital platforms for data management and remote monitoring. Such innovations are particularly relevant given the increasing ubiquity of telehealth. The home administration of FBT can be synergistically supported by digital tools that facilitate clinician-family communication, symptom tracking, and psychoeducation. This hybridization of in-person and remote modalities addresses logistical constraints while maintaining therapeutic fidelity.

Importantly, the correction indicates a meticulous ethical framework governing participant engagement, confidentiality, and safety monitoring. Working within the intimate confines of the family home necessitates stringent ethical safeguards to prevent therapeutic boundary violations and ensure adolescent autonomy. This aspect of the trial design reiterates the commitment to uphold rigorous standards even as the treatment environment deviates from conventional clinical spaces.

In conclusion, this correction to the family-based treatment study underscores a transformative vision for adolescent eating disorder interventions. By situating therapy within the home and embracing the complexity of co-occurring mental health conditions through a mixed methods lens, the research paves pathways toward more effective, accessible, and person-centered care. As psychiatric research continues to evolve, such integrative and context-sensitive models are poised to become the vanguard of mental health treatment for vulnerable youth populations.

Looking ahead, the findings from this trial may instigate a paradigm shift across clinical, academic, and policy domains. They challenge entrenched modalities, advocate for systemic ripples in treatment delivery, and highlight the centrality of family systems within psychiatric recovery. As awareness around adolescent mental health burgeons, innovations like home-based family therapy could herald a new epoch in psychiatric care characterized by compassion, precision, and high-impact outcomes.

Subject of Research: Family-based treatment at home for adolescents with eating disorders and co-occurring mental health conditions

Article Title: Correction: Family-based treatment at home in adolescents with eating disorders and co-occurring mental health conditions: rationale and study design of a mixed methods trial

Article References:
Schapink, A.H., van der Velde, J., Winkelhorst, K. et al. Correction: Family-based treatment at home in adolescents with eating disorders and co-occurring mental health conditions: rationale and study design of a mixed methods trial. BMC Psychiatry 25, 1042 (2025). https://doi.org/10.1186/s12888-025-07489-6

Image Credits: AI Generated

Pulmonary GGNs serve as enigmatic indicators within thoracic radiology, often manifesting with diverse pathological behaviors ranging from benign inflammation to invasive adenocarcinoma. Historically, their heterogeneous nature has posed formidable challenges in establishing optimal surgical interventions. The ability to preoperatively discern the infiltration status of GGNs would revolutionize clinical decision-making, guiding surgeons towards tailored operative procedures—lobectomy or sublobectomy—while simultaneously refining postoperative therapeutic strategies.

The cornerstone of this pioneering study lies in harnessing radiomics—a nuanced analytical technique that transforms standard medical images into high-dimensional data sets quantifying tumor phenotypes beyond human visual perception. The researchers meticulously delineated regions of interest (ROIs) on CT images within lung window settings using the ITK-SNAP platform. This process involved extracting an extensive spectrum of imaging features encompassing morphological descriptors, first-order statistical metrics, intricate texture variables, and higher-order radiomic characteristics, thereby assembling a comprehensive dataset reflective of GGN heterogeneity.

To distill the most prognostically relevant variables from this vast feature pool, the study deployed the Least Absolute Shrinkage and Selection Operator (Lasso) algorithm. This regularization method adeptly minimizes redundancy and overfitting by penalizing less significant features, allowing the model to concentrate on variables with true predictive value. The filtered characteristics were then integrated as inputs into a tailored neural network model designed to decode complex, nonlinear relationships embedded within the image-derived data.

At the algorithmic core, the neural network architecture amalgamated a three-dimensional convolutional neural network (3D CNN) framework, which caters to volumetric CT data, with innovative data augmentation strategies employing random rotations. This augmentation was critical for enhancing the model’s robustness and generalizability, countering the typical pitfalls of limited medical imaging data sets. Moreover, the network capitalized on pre-trained parameters, optimizing training efficiency and leveraging prior knowledge encoded from similar imaging domains.

Validation of the radiomics-incorporated neural network underscored its potent predictive prowess. The model achieved an impressive area under the receiver operating characteristic curve (AUC) of 0.85 during primary evaluation, indicating strong discrimination capabilities in classifying GGN infiltration status. Subsequent validation cohorts yielded respectable AUC values of 0.66 and 0.71, underscoring the model’s consistency across diverse institutional data sources and patient populations.

Crucially, the clinical ramifications of this technology manifested in measurable reductions in surgical mismatch rates. Specifically, the predicted mismatch rate between lobectomy and sublobectomy—a pivotal surgical decision axis—dropped by over 35%, settling at a substantially decreased 21.48%. Furthermore, intra-sublobectomy mismatch rates were curtailed by nearly 14%, reaching a low of 10.73%, affirming the model’s ability to refine subtler clinical distinctions within less extensive resections.

The implications extend beyond mere statistical improvements; reducing mismatch rates translates into tangible benefits for patients. By correctly aligning surgical extent with the biological aggressiveness of GGNs, this tool promises to minimize unnecessary extensive resections that may impair lung function, while simultaneously ensuring aggressive tumors receive appropriately comprehensive treatment. This precise tailoring marks a paradigm shift towards personalized thoracic oncology care, reducing both morbidity and mortality.

One of the notable strengths of this approach is its reliance on widely available CT imaging modalities, circumventing the need for invasive biopsies or sophisticated molecular assays that may delay intervention. Incorporating neural network models into routine radiologic workflows could therefore democratize access to predictive analytics, especially in resource-constrained settings where expert radiopathological interpretation is limited.

Nevertheless, as with any emergent technology, considerations about model interpretability and clinical integration remain. While neural networks exhibit unrivaled pattern recognition capabilities, their ‘black box’ nature can hinder clinician trust and adoption. Future work directed at elucidating feature importance and providing explainable outputs will be essential in bridging this gap, fostering collaborative synergy between artificial intelligence and clinical expertise.

Additionally, this study’s retrospective multicenter design imbues the findings with a degree of external validity, although prospective and randomized controlled trials remain imperative to fully ascertain efficacy and safety in real-world settings. Integration with multi-omics data and exploration of longitudinal imaging changes could further augment the predictive accuracy and expand the model’s applicability to other pulmonary pathologies.

Beyond lung cancer, the methodological framework established here portends a broader revolution in surgical oncology, where radiomics and deep learning converge to unravel tumor biology from imaging alone. This aligns with the overarching goals of precision medicine: delivering the right treatment to the right patient at the right time, maximizing therapeutic benefits while minimizing harm.

The study clearly marks a milestone in contemporary cancer imaging, illustrating how cutting-edge computational tools, when thoughtfully married with clinical acumen, can transform diagnostic paradigms. As artificial intelligence continues to permeate healthcare, such integrative research efforts are pivotal in translating algorithmic innovation into meaningful patient outcomes.

Ultimately, the fusion of CT-based radiomics with neural network models offers a promising avenue for the preoperative assessment of pulmonary GGNs, serving clinicians with an objective, data-driven compass to navigate complex surgical decisions. This novel predictive tool embodies the future of personalized oncologic surgery, embodying hope for improved survival and quality of life among lung cancer patients worldwide.

The progression from rigid heuristic protocols to fluid, individualized treatment schemas underscores the enduring evolution of thoracic surgery. The implications of this work extend beyond mere academic interest; they herald actionable change in clinical pathways, with profound consequences for the millions affected by pulmonary nodular diseases annually.

Ongoing advancements in computational power, image acquisition, and artificial intelligence algorithms portend continuous refinement and expansion of such predictive models. Collaboration across multidisciplinary teams encompassing radiologists, surgeons, data scientists, and oncologists will be crucial to fully harness this potential and ensure robust, ethical deployment.

In conclusion, the integration of CT radiomics and neural networks represents a watershed moment in pulmonary medicine, setting a new standard for preoperative evaluation strategies. This technologically empowered approach promises a future where surgical mismatches become relics of the past, replaced by precision treatments aligned seamlessly with tumor biology and patient needs.

Subject of Research: Preoperative prediction of pulmonary ground-glass nodule infiltration status using CT-based radiomics combined with neural networks.

Article Title: Preoperative prediction of pulmonary ground-glass nodule infiltration status by CT-based radiomics combined with neural networks.

Article References:
Mei, K., Feng, Z., Liu, H. et al. Preoperative prediction of pulmonary ground-glass nodule infiltration status by CT-based radiomics combined with neural networks. BMC Cancer 25, 659 (2025). https://doi.org/10.1186/s12885-025-14027-w

Image Credits: Scienmag.com

DOI: https://doi.org/10.1186/s12885-025-14027-w